In the current study, we investigated the effect of TRPV1 blockade on hyperglycemia indirectly by assessing oral glucose tolerance (i.e., the ability to clear orally administered glucose), both as a direct measurement of blood glucose and the insulin response to oral glucose. Here, TRPV1 is linked to Hyperglycemia.